US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 34.540
  • -0.040-0.12%
Close May 3 16:00 ET
  • 35.130
  • +0.590+1.71%
Post 17:30 ET
1.96BMarket Cap-5473P/E (TTM)

Agios Pharmaceuticals Key Stats

Agios Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

8.19M

+46.00%
EPS(YoY)

-1.45

+1.36%

Strong Buy

May 3, 2024

Agios Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 33.332M--
--2024/Q2-- / 9.518M--
May 2, 20242024/Q18.189M / 8.372M--
Feb 15, 20242023/Q47.103M / 7.924M--
Nov 2, 20232023/Q37.399M / 7.526M--
Aug 3, 20232023/Q26.712M / 6.463M--
May 4, 20232023/Q15.609M / 5.234M--
Feb 23, 20232022/Q44.310M / 4.534M--
Nov 3, 20222022/Q33.516M / 5.238M--
Aug 4, 20222022/Q25.582M / 2.861M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 33.332M--
--2024/Q2-- / 9.518M--
May 2, 20242024/Q18.189M / 8.372M--
Feb 15, 20242023/Q47.103M / 7.924M--
Nov 2, 20232023/Q37.399M / 7.526M--
Aug 3, 20232023/Q26.712M / 6.463M--
May 4, 20232023/Q15.609M / 5.234M--
Feb 23, 20232022/Q44.310M / 4.534M--
Nov 3, 20222022/Q33.516M / 5.238M--
Aug 4, 20222022/Q25.582M / 2.861M--

Unlock Free Earnings Estimates

Agios Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 3, 2024

Strong Buy

  • Buy

    87.50%
  • Hold

    12.50%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg